本帖最后由 成长的烦恼 于 2012-6-27 20:19 编辑
1 G+ i6 w9 ?2 a* E8 s, f
5 B: p4 ? g4 q& Cclinicaltrials上的三期临床链接
1 q6 f1 b8 o; h N4 N) ~% X& w( f. p
& r/ ^ Y2 H) G1 Y0 n2 Q# P+ o' Rhttp://clinicaltrials.gov/ct2/sh ... mp;show_locs=Y#locn
/ X$ k9 j9 O3 u4 j2 T- Y* k) f& e: [- B2 _/ g
中国参加临床实验的城市
# A% a: e0 L6 \* G, }* e8 n
4 n, o5 |' D) \China, Guangdong 0 E( s. \5 I, h% W
8 Y" O# s, R- b$ Z1 C1 S
Guangzhou, Guangdong, China, 510515 1 B4 b- A. l y( Z
6 m( E- g1 p3 h; |
Guangzhou, Guangdong, China, 510060 $ v# i! x, W/ Y8 U1 a
China, Jiangsu
& D, U+ u7 ?" C6 F2 Q( e* u
3 o( i/ F! U0 O9 FNanjing, Jiangsu, China, 210009 ) @- m% }( B/ p8 b1 g( M
' a# U4 ~5 @( [1 @% s% _
Nanjing, Jiangsu, China, 210002 : }0 a* d0 `0 _7 J
China, Shandong . m+ M) \/ q0 C& U
% g9 U5 ]' x+ i( W% ]. F3 ]6 BQingdao, Shandong, China, 266003
' Z3 p& y) _! y6 B& ?1 U/ b" b z# LChina ; D" w! M b5 G% e
+ G/ v: i# C/ j! jBeijing, China, 100021
1 ]/ ]: F% \6 t" x) y3 r % R! b+ F$ C; w, z" t3 z
Beijing, China, 100071
/ l7 q- X, ], }7 ] " z! @0 D# y( z3 ]9 D
Changchun, China, 130021 , b+ h* K9 U/ o8 T0 D
+ D2 c% n2 S- i e
Chongqing, China, 400042
0 i' Q% z4 Z4 O- l) t& l/ J6 ]
h9 i% B1 D) O+ [" U3 W8 }Chongqing, China, 400038
: Q8 w% o2 J7 m0 i- I- |. T. V6 I
7 r. c8 k' f: i: ?/ I7 yFuzhou, China, 350014
) n* g8 z8 b0 r" u
6 |5 v' z4 s9 \/ x6 {: Q* }: FFuzhou, China, 350025 . Y. [3 o& P- A: c" ]- K
5 v) o2 p2 @; ?9 ^1 e7 @
Ha'erbin, China, 150040 7 j: c/ T2 U* g# P6 O' D. H* m
; B5 q8 Z8 k( U; Q: F' t3 M
Hanghzou, China, 310009
# ?5 r$ d. q* `) C5 p$ A
: g; z) P/ B# LShanghai, China, 200001
3 ^4 _4 ]0 N) G 5 U$ U, r" ^0 O: t& r6 y. n
Shanghai, China, 200030
1 B" V0 X9 V3 | & k+ W! r; X6 `& t
Tianjin, China
7 {4 k8 q; E- c' K/ K
# g+ E+ x. A% L3 f: _该实验已停止招募,重新开的临床请见临床专用贴。 |